首页> 美国卫生研究院文献>Haematologica >Non-Hodgkin lymphoma in the developing world: review of 4539 cases from the International Non-Hodgkin Lymphoma Classification Project
【2h】

Non-Hodgkin lymphoma in the developing world: review of 4539 cases from the International Non-Hodgkin Lymphoma Classification Project

机译:发展中国家的非霍奇金淋巴瘤:来自国际非霍奇金淋巴瘤分类项目的4539例病例回顾

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The distribution of non-Hodgkin lymphoma subtypes varies around the world, but a large systematic comparative study has never been done. In this study, we evaluated the clinical features and relative frequencies of non-Hodgkin lymphoma subtypes in five developing regions of the world and compared the findings to the developed world. Five expert hematopathologists classified 4848 consecutive cases of lymphoma from 26 centers in 24 countries using the World Health Organization classification, and 4539 (93.6%) were confirmed to be non-Hodgkin lymphoma, with a significantly greater number of males than females in the developing regions compared to the developed world (P<0.05). The median age at diagnosis was significantly lower for both low- and high-grade B-cell lymphoma in the developing regions. The developing regions had a significantly lower frequency of B-cell lymphoma (86.6%) and a higher frequency of T- and natural killer-cell lymphoma (13.4%) compared to the developed world (90.7% and 9.3%, respectively). Also, the developing regions had significantly more cases of high-grade B-cell lymphoma (59.6%) and fewer cases of low-grade B-cell lymphoma (22.7%) compared to the developed world (39.2% and 32.7%, respectively). Among the B-cell lymphomas, diffuse large B-cell lymphoma was the most common subtype (42.5%) in the developing regions. Burkitt lymphoma (2.2%), precursor B- and T-lymphoblastic leukemia/lymphoma (1.1% and 2.9%, respectively) and extranodal natural killer/T-cell lymphoma (2.2%) were also significantly increased in the developing regions. These findings suggest that differences in etiologic and host risk factors are likely responsible, and more detailed epidemiological studies are needed to better understand these differences.
机译:非霍奇金淋巴瘤亚型的分布在世界各地有所不同,但从未进行过大规模的系统比较研究。在这项研究中,我们评估了世界上五个发展中地区的非霍奇金淋巴瘤亚型的临床特征和相对频率,并将发现与发达国家进行了比较。五名专业血液病理学家使用世界卫生组织的分类方法,对来自24个国家/地区的26个中心的4848例连续淋巴瘤病例进行了分类,其中4539例(93.6%)被确认为非霍奇金淋巴瘤,在发展中地区,男性的数量明显多于女性。与发达国家相比(P <0.05)。在发展中地区,低度和高度B细胞淋巴瘤的诊断中位年龄均明显较低。与发达地区(分别为90.7%和9.3%)相比,发展中地区的B细胞淋巴瘤发生率明显较低(86.6%),而T细胞淋巴瘤和自然杀伤细胞淋巴瘤的发生率较高(分别为13.4%)。此外,与发达地区(分别为39.2%和32.7%)相比,发展中地区的高级别B细胞淋巴瘤病例(59.6%)和低级B细胞淋巴瘤病例(22.7%)显着增加。 。在B细胞淋巴瘤中,弥漫性大B细胞淋巴瘤是发展中地区最常见的亚型(42.5%)。在发展中地区,伯基特淋巴瘤(2.2%),前体B和T淋巴细胞白血病/淋巴瘤(分别为1.1%和2.9%)和结外自然杀伤/ T细胞淋巴瘤(2.2%)也显着增加。这些发现表明,病因和宿主风险因素的差异可能是原因,因此需要更详细的流行病学研究才能更好地理解这些差异。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号